MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-06-2026
Mettler-Toledo International ROE Ratio 2011-2026 | MTD
Annual ROE Ratio Mettler-Toledo International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3677.41 | -680.23 | -526.07 | 3519.15 | 448.59 | 213.23 | 133.35 | 86.87 | 68.7 | 88.37 | 60.78 | 47.0 | 32.74 | 35.16 | 34.5 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3519.15 | -3677.41 | -7.68 |
Quarterly ROE Ratio Mettler-Toledo International
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -392.39 | -442.15 | -509.16 | -394.08 | -584.52 | -637.94 | -731.21 | -1198.99 | -1465.38 | -1541.32 | 1617.42 | 2859.63 | 2961.13 | 3355.49 | 531.74 | 399.85 | 374.86 | 304.12 | 252.37 | 213.23 | 182.52 | 156.04 | 141.49 | 133.35 | 118.25 | 108.96 | 97.63 | 86.87 | 70.23 | 117.47 | 167.27 | 172.48 | 190.1 | 209.77 | 229.44 | 296.79 | 286.37 | 258.78 | 231.19 | 203.6 | 199.19 | 185.41 | 171.63 | 157.85 | 152.79 | 138.53 | 124.26 | 109.99 | 110.86 | 113.28 | 115.7 | 118.13 | 117.55 | 116.89 | 116.23 | 115.57 | 34.5 | 34.5 | 34.5 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3355.49 | -1541.32 | 181.33 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
12.35 | $ 9.24 | 2.72 % | $ 616 M |  USA |
|
Biodesix
BDSX
|
-205.65 | $ 15.58 | 6.06 % | $ 2.02 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 16.29 | -0.28 % | $ 493 M | USA |
 |
Guardant Health
GH
|
419.18 | $ 83.67 | -1.52 % | $ 10.5 B | USA |
 |
IDEXX Laboratories
IDXX
|
65.99 | $ 573.49 | -0.87 % | $ 46.1 B | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 74.3 | -1.89 % | $ 5.01 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 464.6 | 1.68 % | $ 13.4 B | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 4.68 | 0.54 % | $ 433 M | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 17.21 | -1.71 % | $ 385 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Pacific Biosciences of California
PACB
|
-10214.54 | $ 1.39 | - | $ 417 M | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Precipio
PRPO
|
-40.56 | $ 27.01 | 0.3 % | $ 35.1 M | USA |
 |
Personalis
PSNL
|
-40.05 | $ 7.78 | 2.23 % | $ 461 M | USA |
 |
Co-Diagnostics
CODX
|
-41.08 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
RadNet
RDNT
|
-1.71 | $ 59.45 | -3.71 % | $ 4.47 B | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Senseonics Holdings
SENS
|
-113.21 | $ 6.7 | 1.21 % | $ 280 M | USA |
 |
Sotera Health Company
SHC
|
12.86 | $ 13.87 | -0.11 % | $ 3.94 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Soleno Therapeutics
SLNO
|
4.64 | $ 31.01 | -2.25 % | $ 1.58 B | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 159.89 | 1.2 % | $ 7.92 B | USA |
 |
IQVIA Holdings
IQV
|
20.91 | $ 167.87 | 0.55 % | $ 28.9 B | USA |
 |
Neuronetics
STIM
|
-174.27 | $ 1.49 | -6.88 % | $ 98.3 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
-59.42 | $ 1.19 | -18.49 % | $ 6.48 M | USA |
 |
Interpace Biosciences
IDXG
|
-302.3 | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 125.94 | 1.74 % | $ 20 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 46.98 | 5.57 % | $ 2.81 B | USA |
 |
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B |  Niderland |
 |
Celcuity
CELC
|
-96.68 | $ 102.11 | -4.35 % | $ 4.03 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 266.04 | 0.61 % | $ 22.1 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
ENDRA Life Sciences
NDRA
|
-449.46 | $ 3.49 | 0.29 % | $ 1.87 M | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 7.92 | -2.28 % | $ 1.01 B | USA |
 |
Natera
NTRA
|
-77.62 | $ 195.76 | -2.17 % | $ 19.3 B | USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 17.83 | 1.54 % | $ 950 M | USA |
 |
OPKO Health
OPK
|
1.03 | $ 1.12 | -2.61 % | $ 777 M | USA |